Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-005318
Filing Date
2023-02-16
Accepted
2023-02-16 20:05:41
Documents
1
Period of Report
2023-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6111
  Complete submission text file 0000899243-23-005318.txt   7431
Mailing Address 2843-122 PL. N.E. BELLEVUE WA 98005
Business Address
REED STEVEN (Reporting) CIK: 0001229760 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41390 | Film No.: 23640016

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Issuer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks